MN4000 for Treatment of CF and MND Patients in the Home Setting

על הניסוי

The study was a non-randomized open label pilot study. It was an observational design conducted at one (1) site in the US. All enrolled subjects received treatment with the MN4000. This pilot study evaluated subject satisfaction with the therapy and adherence to the therapy during the 90-day treatment period, and also collected clinical outcome data. Outcomes were assessed before, during and after the MN4000 treatment period.

צפו ב-NCT03797677 ב-ClinicalTrials.gov ←

קישורים קשורים